Tolerability and toxicity of trastuzumab or trastuzumab?+?lapatinib in older patients: a sub-analysis of the ALTTO trial (BIG 2-06; NCCTG (Alliance) N063D).
Auteurs : Pondé N, Agbor-Tarh D, Dal Lago L, Korde LA, Hilbers F, Jackisch C, Werner O, Gelber Rd, Jatoi A, Dueck AC, Moreno-Aspitia A, Sotiriou C, de Azambuja E, Piccart-Gebhart M Année : 2021 Journal : Breast Cancer Res Treat
Rare Features of Dermatomyositis in a Patient with Ovarian Cancer.
Auteurs : Dal Lago L, Vandergheynst F, Awada A, Pepersack T Année : 2020 Journal : Eur J Case Rep Intern Med
The added value of geriatric assessment in evaluating a patient's Health-Related Quality-of-Life: A study in ≥70-year-old early-stage invasive breast cancer patients.
Auteurs : Quinten C, Kenis C, Hamaker M, Coolbrandt A, Brouwers B, Dal Lago L, Neven P, Vuylsteke P, Debrock G, Van den Bulck H, Smeets A, Schöffski P, Wedding U, Wildiers H Année : 2020 Journal : Eur J Cancer Care (Engl)
Use of granulocyte-colony stimulating factors in older patients: a review of recently published data.
Auteurs : Klastersky J, Dal Lago L, Lalami Y Année : 2020 Journal : Curr Opin Oncol
Anti-HER2 therapy for breast cancer in older patients.
Auteurs : Goldner M, Franzoi MA, Dal Lago L, Pondé N Année : 2020 Journal : Future Oncol